Skip to main content

Rheumatoid Arthritis: The Use of Somatostatin Analogs. When and How?

  • Conference paper
Nuclear Medicine in the Management of Inflammatory and Infectious Diseases

Abstract

The use of somatostatin analogs in nuclear medicine procedures has been centered on the oncological diagnostic procedures that can be accomplished using these peptides.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Blum AM, Metwali A, Mathew RC, Cook G, Elliott D, Weinstock JV (1992) Granuloma T lymphocytes in murine schistosomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFN-gamma secretion. J Immunol 149: 3621–3626

    PubMed  CAS  Google Scholar 

  • Elliott DE, Li J, Blum AM, Metwali A, Patel YC, Weinstock JV (1999) SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-gamma release. Eur J Immunol 29: 2454–2463

    Article  PubMed  CAS  Google Scholar 

  • Padberg WM, Morgalla H, Buhr J, Hild P, Schwemmle K (1991) Immunosuppressive action of somatostatin and the somatostatin analogue SMS 201–995 and their synergistic effect with low-dose cyclosporine A in organ transplantation. Transplant Proc 23: 348–348

    PubMed  CAS  Google Scholar 

  • Perego C, Lattuada D, Casnici C, et al (1998) Evidence that SMS 201–995 enhances the immunosuppressive effect of FK506. Int J Immunopharmacol. 20: 479–490

    Article  PubMed  CAS  Google Scholar 

  • Reubi JC, Waser B, Horisberger U, et al (1993) In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. Blood 82: 2143–2151

    PubMed  CAS  Google Scholar 

  • Van Hagen PM, Krenning EP, Kwekkeboom DJ, et al (1994) Somatostatin and the immune and haematopoetic system: a review. Eur J Clin Invest 24: 91–99

    Article  PubMed  Google Scholar 

  • Vehmeyer K, Schuff-Werner P, Nagel GA (1986) Suppressed colony formation of peripheral blood lymphocytes in a patient with somatostatinoma. Clin Immunol Immunopathol 41: 290–294

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Moncayo, R. (2003). Rheumatoid Arthritis: The Use of Somatostatin Analogs. When and How?. In: Signore, A., Liberatore, M., Scopinaro, F. (eds) Nuclear Medicine in the Management of Inflammatory and Infectious Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05289-1_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-05289-1_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-07871-2

  • Online ISBN: 978-3-662-05289-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics